Capital Financial Planning LLC purchased a new stake in CME Group Inc (NASDAQ:CME) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 210 shares of the financial services provider’s stock, valued at approximately $40,000.
Several other large investors have also recently added to or reduced their stakes in CME. Covington Capital Management bought a new stake in CME Group during the 4th quarter worth approximately $49,000. AE Wealth Management LLC bought a new stake in CME Group during the 4th quarter worth approximately $291,000. British Airways Pensions Investment Management Ltd increased its stake in CME Group by 0.9% during the 4th quarter. British Airways Pensions Investment Management Ltd now owns 110,899 shares of the financial services provider’s stock worth $20,879,000 after purchasing an additional 1,017 shares in the last quarter. Legal & General Group Plc increased its stake in CME Group by 12.6% during the 4th quarter. Legal & General Group Plc now owns 1,816,140 shares of the financial services provider’s stock worth $341,605,000 after purchasing an additional 203,486 shares in the last quarter. Finally, Thrivent Financial for Lutherans increased its stake in CME Group by 8.2% during the 4th quarter. Thrivent Financial for Lutherans now owns 15,815 shares of the financial services provider’s stock worth $2,975,000 after purchasing an additional 1,194 shares in the last quarter. 84.85% of the stock is currently owned by institutional investors.
Shares of NASDAQ CME traded up $0.48 during trading hours on Monday, hitting $173.40. The company had a trading volume of 1,093,704 shares, compared to its average volume of 1,813,328. The company has a market cap of $61.87 billion, a PE ratio of 25.43, a PEG ratio of 3.48 and a beta of 0.29. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 0.15. CME Group Inc has a 1-year low of $153.90 and a 1-year high of $197.08.
The firm also recently declared a quarterly dividend, which was paid on Monday, March 25th. Shareholders of record on Friday, March 8th were issued a dividend of $0.75 per share. This is an increase from CME Group’s previous quarterly dividend of $0.70. The ex-dividend date was Thursday, March 7th. This represents a $3.00 annualized dividend and a yield of 1.73%. CME Group’s dividend payout ratio (DPR) is currently 43.99%.
A number of research firms recently issued reports on CME. Citigroup set a $205.00 target price on CME Group and gave the stock a “buy” rating in a research note on Friday, February 15th. BidaskClub downgraded CME Group from a “buy” rating to a “hold” rating in a research report on Thursday, January 31st. JPMorgan Chase & Co. began coverage on CME Group in a research report on Friday, February 15th. They set an “underweight” rating and a $164.00 price target for the company. ValuEngine downgraded CME Group from a “buy” rating to a “hold” rating in a research report on Wednesday, March 20th. Finally, Deutsche Bank reduced their price target on CME Group from $220.00 to $214.00 and set a “buy” rating for the company in a research report on Friday, March 15th. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have assigned a buy rating to the company. CME Group has an average rating of “Hold” and an average price target of $192.00.
In other CME Group news, Director Jeffrey M. Bernacchi sold 10,087 shares of the stock in a transaction on Tuesday, February 26th. The stock was sold at an average price of $177.94, for a total transaction of $1,794,880.78. Following the transaction, the director now owns 42,004 shares in the company, valued at approximately $7,474,191.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Julie Holzrichter sold 4,362 shares of the stock in a transaction on Friday, March 1st. The stock was sold at an average price of $182.45, for a total value of $795,846.90. Following the transaction, the chief operating officer now owns 41,265 shares in the company, valued at approximately $7,528,799.25. The disclosure for this sale can be found here. Insiders have sold a total of 28,489 shares of company stock valued at $4,948,996 in the last ninety days. Insiders own 1.20% of the company’s stock.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Recommended Story: Net Income
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.